Navigation Links
ACO Proposed Rule: Nine out of Ten Quality Measures Mirror Other Quality Reporting Programs
Date:4/4/2011

EMERYVILLE, Calif., April 4, 2011 /PRNewswire/ -- Newly proposed Medicare rules designed to promote and reward high-quality patient care under healthcare reform closely mirror quality reporting programs already well established as part of the American healthcare system, a MedeAnalytics analysis has found.

(Logo:  http://photos.prnewswire.com/prnh/20100621/SF23660LOGO)

The quality measure analysis is included in MedeAnalytics' white paper, "Accountable Care Organizations: Summary and Analysis of the Proposed Rule," available at the company's Accountable Care Organization (ACO) Resource Center. MedeAnalytics is a healthcare performance management firm that collects and analyzes data to help hospitals, physician practices and payers ensure accountability and improve financial, operational and clinical outcomes, a key element of successfully managing ACOs.

The proposed rule issued by the Department of Health and Human Services on March 31, 2011 specifies 65 quality measures, of which 58 overlap with one or more other quality reporting programs, MedeAnalytics found. The other quality measurement programs include the Agency for Healthcare Research and Quality (AHRQ) Prevention Quality Indicators and Patient Safety Indicators, the Healthcare Effectiveness and Data Information Set (HEDIS), Meaningful Use Stage 2, the Physician Quality Reporting System (PQRS), and the Value-Based Purchasing (VBP) program.

"The high degree of commonality for quality measures should help ACOs meet the Shared Savings Program's year 1 quality performance standards, since healthcare providers are quite familiar with their nature, required data collection methods and reporting processes," commented Mino Sastry, MPH, a product marketing manager for MedeAnalytics' provider solutions.  

About ACOsWhile the ACO label has been around since 2006, it was mentioned in numerous healthcare reform bills proposed in 2009 and was ultimately included in Section 3022 of the Patient Protection and Affordable Care Act (ACA) as the Medicare Shared Savings Program. The ACA's ACO provision covers Medicare ACOs. The Shared Savings Program is a new approach to the delivery of healthcare aimed at: (1) better care for individuals; (2) better health for populations; and (3) lower growth in expenditures.

About MedeAnalyticsFounded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit www.medeanalytics.com.For more information:

MedeAnalytics, Inc.Bruce Lewis

5858 Horton Street, Suite 475 Lewis & Summers Public Relations

Emeryville, CA  94608 (707) 813-1197bruce@prwebsite.com
'/>"/>

SOURCE MedeAnalytics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ACO Proposed Rule: Over 90 Percent of Commercial Payer RFI Suggestions Incorporated
2. ACO Proposed Rule Simplified: MedeAnalytics Releases Comprehensive White Paper
3. Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants
4. Amarin Announces Proposed Public Offering of American Depositary Shares
5. AVANIR Pharmaceuticals Announces Proposed Public Offering of Common Stock
6. PharmAthene Announces Proposed Common Stock Offering
7. OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering
8. Mylan Announces Proposed Add-On Private Placement of its Senior Notes Due 2020
9. Complaint Filed Regarding Proposed Merger
10. InterMune Announces Proposed Public Offering of Common Stock
11. Dendreon Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):